Physician profile
Jeffrey Ho
NPI 1265761951
$8,406.76
in general payments reported to CMS, 2019-2025
15 companies · $969 in 2025
The $969 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $1,210 · 2021: $33.86 · 2022: $231 · 2023: $2,272 · 2024: $2,753 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,535 · Food and Beverage: $1,758 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,700 · Travel and Lodging: $1.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,535.00 |
| Food and Beverage | $1,758.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,700.00 |
| Travel and Lodging | $1.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $5,395.00 | 2020-2024 | Acuson Sequoia Diagnostic Ultrasound System |
| Boston Scientific Corporation | $1,168.06 | 2019-2025 | Farapulse, Watchman |
| Biosense Webster, INC. | $964.30 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic, INC. | $516.69 | 2022-2025 | Micra, Affera Mapping System, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $129.57 | 2025 | Ensite, Aveir |
| Amgen INC. | $42.11 | 2024-2025 | Repatha, Repatha |
| Penumbra, INC. | $33.86 | 2021 | |
| United Therapeutics Corporation | $24.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.59 | 2025 | |
| Biotissue Holdings INC. | $22.55 | 2023 | |
| Cordis US Corp. | $20.92 | 2025 | Mynx Control Venous |
| Cardiva Medical, INC. | $18.17 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $17.39 | 2019 | |
| Novo Nordisk INC | $16.18 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.